Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA international memorandum of understanding policy formalized.

This article was originally published in The Gray Sheet

Executive Summary

FDA MEMORANDUM OF UNDERSTANDING POLICY FORMALIZED in a compliance policy guide published in the June 15 Federal Register. Formulated in response to a recommendation in a December 1992 report of the agency's International Harmonization Task Force ("The Gray Sheet" Jan. 25, 1993, p. 6), the policy outlines general principles for developing MOUs with foreign governments and international organizations, as well as procedures for initiating and monitoring such agreements.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT004281

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel